Back to Startups

Imagene AI

Bioscience & Disease Healthcare Systems AI, ML, Gen AI
Bioscience & Disease Healthcare Systems AI, ML, Gen AI Show less
Bioscience & Disease Healthcare Systems +1
Bioscience & Disease Healthcare Systems AI, ML, Gen AI Show less
Website LinkedIn San Francisco , California , USA
About Imagene AI

Imagene AI is focused on AI-driven cancer detection, leveraging advanced machine learning techniques to enhance precision medicine and improve patient outcomes.

Business Information
Target Customers
hospitals research institutions oncologists pharmaceutical companies
Industry Categories
Bioscience & Disease Healthcare Systems AI, ML, Gen AI
Business Model
Revenue Model SaaS
Pricing Strategy Subscription-based
Sales Channels direct sales, partnerships with healthcare providers
Funding Timeline
Round Date Amount Investors
Series B Jul 04, 2025 $23.0M Larry Ellison
Founders

No founder information available.

Investors
L
Larry Ellison

Angel Investor, Corporate Investor

Recent Mentions
ai_24x7
The AI Showdown 24x7 @ai_24x7
Jul 05, 2025

LARRY ELLISON BACKS AI CANCER FIGHT Imagene AI, a startup focused on AI-driven cancer detection, has raised $23 million in a Series B round led by Larry Ellison, bringing its total funding to $45 million, as reported by The AI Insider on July 4, 2025. The company’s technology https://t.co/msF9OPleHA

View on Twitter
Similar Startups
Rad AI
89% match

Rad AI leverages artificial intelligence to enhance radiology workflows, improving efficiency and ac...
AppliedAI
89% match

AppliedAI is a cutting-edge technology startup focused on leveraging artificial intelligence to prov...
Enterprise GenAI
88% match

Enterprise GenAI is a cutting-edge startup focused on leveraging artificial intelligence to enhance ...
Pathos AI
88% match

Pathos AI is a Boston-based biotech company focused on AI-driven oncology, leveraging advanced artif...